The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Antimicrobial Resistance among Campylobacter Strains, United States, 1997–2001
Open accessAbstract
We summarize antimicrobial resistance surveillance data in human and chicken isolates of Campylobacter.Isolates were from a sentinel county study from 1989 through 1990 and from nine state health departments participating in National Antimicrobial Resistance Monitoring System for enteric bacteria (NARMS) from 1997 through 2001.None of the 297 C. jejuni or C. coli isolates tested from 1989 through 1990 was ciprofloxacin-resistant. From 1997 through 2001, a total of 1,553 human Campylobacter isolates were characterized: 1,471 (95%) were C. jejuni, 63 (4%) were C. coli, and 19 (1%) were other Campylobacter species.The prevalence of ciprofloxacin-resistant Campylobacter was 13% (28 of 217) in 1997 and 19% (75 of 384) in 2001; erythromycin resistance was 2% (4 of 217) in 1997 and 2% (8 of 384) in 2001.Ciprofloxacin-resistant Campylobacter was isolated from 10% of 180 chicken products purchased from grocery stores in three states in 1999.Ciprofloxacin resistance has emerged among Campylobacter since 1990 and has increased in prevalence since 1997.C ampylobacter is the most common cause of bacterial gastroenteritis in the United States, causing an estimated 2.4 million human infections annually (1).Diagnosed infections have declined in recent years.In 2001, FoodNet surveillance identified 13.4 diagnosed Campylobacter infections per 100,000 persons (2).Approximately 95% of diagnosed Campylobacter infections are due to C. jejuni (3).Although most Campylobacter infections cause an acute, self-limited illness characterized by diarrhea, fever, and abdominal cramps, severe infections do occur (4).Antimicrobial treatment can shorten the duration of illness and may be life-saving in invasive infections (5-7).Fluoroquinolones (e.g., ciprofloxacin) are often prescribed empirically for the treatment of gastroenteritis and for Campylobacter infections in adults (6,8).Quinolones (e.g., nalidixic acid), although now seldom used for treatment in the United States, are frequently used to screen for fluoroquinolone resistance because of the close correlation between quinolone and fluoroquinolone resistance among Campylobacter.Macrolides, such as erythromycin, are also prescribed to treat Campylobacter infections (4,9).Fluoroquinolone-resistant Campylobacter infections in humans were first detected in Europe in the late 1980s (10-12).Subsequently, an increasing proportion of Campylobacter isolates around the world have been found to be fluoroquinolone-resistant (13).Studies in the United States, Europe, and New Zealand have identified poultry as a principal source of Campylobacter infection (14-16).Quinolones have been available in human medicine since the mid-1960s, and the first fluoroquinolone (ciprofloxacin) was approved for use in humans in 1986.Two fluoroquinolones, sarafloxacin and enrofloxacin, were approved for use in poultry by the U.S. Food and Drug Administration (FDA) in 1995 and 1996, respectively (17).These fluoroquinolones were the first ones approved in food animals; subsequently, other fluoroquinolones have been approved for veterinary use but not for use in poultry (18).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Food-Related Illness and Death in the United States
Mead, P. S., Slutsker, L., Dietz, V., McCaig, L. F., Bresee, J. S., Shapiro, C., Griffin, P. M., & Tauxe, R. V. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0505.990502 · Cited by 7,235
Self-citationCampylobacter jejuni Infections: Update on Emerging Issues and Trends
Acheson, D., & Allos, B. M. (2001) · Clinical Infectious Diseases · doi:10.1086/319760 · Cited by 1,216
Campylobacter jejuni—An Emerging Foodborne Pathogen
Altekruse, S. F., Stern, N. J., Fields, P. I., & Swerdlow, D. L. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0501.990104 · Cited by 893
Engberg, J., Aarestrup, F. M., Taylor, D. E., Gerner-Smidt, P., & Nachamkin, I. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010104 · Cited by 696
Quinolone-Resistant Campylobacter jejuni Infections in Minnesota, 1992–1998
Smith, K. E., Besser, J. M., Hedberg, C. W., Leano, F. T., Bender, J. B., Wicklund, J. H., Johnson, B. P., Moore, K. A., & Osterholm, M. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905203402001 · Cited by 666
Self-citationEndtz, H. P., Ruijs, G. J., van Klingeren, B., Jansen, W. H., van der Reyden, T., & Mouton, R. P. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.2.199 · Cited by 590
Zhao, C., Ge, B., De Villena, J., Sudler, R., Yeh, E., Zhao, S., White, D. G., Wagner, D., & Meng, J. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.12.5431-5436.2001 · Cited by 580
Linton, D., Lawson, A. J., Owen, R. J., & Stanley, J. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.10.2568-2572.1997 · Cited by 569
Campylobacter Jejuni: Current Status and Future Trends
Nachamkin, I., Blaser, M. J., & Tompkins, L. S. (1992) · Medical Entomology and Zoology · Cited by 359
Gonzalez, I., Grant, K. A., Richardson, P. T., Park, S. F., & Collins, M. D. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.759-763.1997 · Cited by 270
Campylobacteriosis in New Zealand: results of a case-control study.
Eberhart-Phillips, J., Walker, N., Garrett, N., Bell, D., Sinclair, D., Rainger, W., & Bates, M. (1997) · Journal of Epidemiology and Community Health · doi:10.1136/jech.51.6.686 · Cited by 247
Kuschner, R. A., Trofa, A. F., Thomas, R. J., Hoge, C. W., Pitarangsi, C., Amato, S., Olafson, R. P., Echeverria, P., Sadoff, J. C., & Taylor, D. N. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.3.536 · Cited by 242
Adak, G. K., Cowden, J. M., Nicholas, S., & Evans, H. S. (1995) · Epidemiology and Infection · doi:10.1017/s0950268800058076 · Cited by 218
Antimicrobial-Drug Prescription in Ambulatory Care Settings, United States, 1992–2000
McCaig, L. F., Besser, R. E., & Hughes, J. M. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0904.020268 · Cited by 210
McDermott, P. F., Bodeis, S. M., English, L. L., White, D. G., Walker, R. D., Zhao, S., Simjee, S., & Wagner, D. D. (2002) · The Journal of Infectious Diseases · doi:10.1086/339195 · Cited by 194
Prats, G., Mirelis, B., Llovet, T., Muñoz, C., Miró, E., & Navarro, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1140-1145.2000 · Cited by 156
Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children
Salazar‐Lindo, E., Sack, R. B., Chea-Woo, E., Kay, B. A., Piscoya, Z., León‐Barúa, R., & Yi, A. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80404-8 · Cited by 147
Increasing Fluoroquinolone Resistance inCampylobacter jejuni,Pennsylvania, USA,1982–20011
Nachamkin, I., Ung, H., & Li, M. (2002) · Emerging infectious diseases · doi:10.3201/eid0812.020115 · Cited by 144
Empiric Antimicrobial Therapy of Domestically Acquired Acute Diarrhea in Urban Adults
Goodman, L. J. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390150047009 · Cited by 143
Antimicrobial-Resistant Campylobacter Species from Retail Raw Meats
Ge, B., White, D. G., McDermott, P. F., Girard, W., Zhao, S., Hubert, S., & Meng, J. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.5.3005-3007.2003 · Cited by 136
Kassenborg, H. D., Smith, K., Vugia, D. J., Rabatsky‐Ehr, T., Bates, M. R., Carter, M. A., Dumas, N. B., Cassidy, M., Marano, N. N., Tauxe, R. V., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381597 · Cited by 133
Self-citationCiprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study
Gaunt, P. N., & Piddock, L. J. V. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.4.747 · Cited by 130
Campylobacters, Helicobacters, and Related Organisms
Newell, D. G., Ketley, J. M., & Feldman, R. A. (1996) · Springer eBooks · doi:10.1007/978-1-4757-9558-5 · Cited by 87
Mattila, L., Peltola, H., Siitonen, A., Kyrönseppä, H., Simula, I., & Kataja, M. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.779 · Cited by 85
International Conference on Emerging Infectious Diseases
Smith, A. L. (2003) · JAMA · doi:10.1001/jama.290.20.2658 · Cited by 49
The E-Test and Campylobacter jejuni
Baker, C. N. (1992) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(92)90092-8 · Cited by 47
Patton, C. M., Nicholson, M. A., Ostroff, S. M., Ries, A. A., Wachsmuth, I. K., & Tauxe, R. V. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.6.1525-1530.1993 · Cited by 28
Self-citation
Cited by
Food Animals and Antimicrobials: Impacts on Human Health
Marshall, B. M., & Levy, S. B. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-11 · Cited by 2,241
Global Epidemiology of Campylobacter Infection
Kaakoush, N. O., Castaño-Rodríguez, N., Mitchell, H. M., & Man, S. M. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-15 · Cited by 1,529
Antimicrobial resistance: A global emerging threat to public health systems
Ferri, M., Ranucci, E., Romagnoli, P., & Giaccone, V. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1077192 · Cited by 1,049
Agriculture and food animals as a source of antimicrobial-resistant bacteria
Economou, V., & Gousia, P. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s55778 · Cited by 761
Industrial Food Animal Production, Antimicrobial Resistance, and Human Health
Silbergeld, E. K., Graham, J., & Price, L. B. (2008) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.29.020907.090904 · Cited by 635
Metadata
- Authors
- Gupta, A., Nelson, J. M., Barrett, T. J., Tauxe, R. V., Rossiter, S. P., Friedman, C. R., Joyce, K. W., Smith, K. E., Jones, T. F., Hawkins, M. A., Shiferaw, B., Beebe, J. L., Vugia, D. J., Rabatsky-Ehr, T., Benson, J. A., Root, T. P., Angulo, F. J., & for the NARMS Working Group
- Venue
- Emerging Infectious Diseases
- Published
- 2004-06
- Volume
- 10
- Issue
- 6
- Pages
- 1102-1109
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2045954937
- Cited by
- 269
- References
- 30
- FWCI
- 31.25
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.